FDA Issues Draft Guidance on Use of Data Monitoring Committees in Clinical Trials | King & Spalding

The U.S. Food and Drug Administration (FDA or Agency) has issued draft guidance, Use of Data Monitoring Committees in Clinical Trials, that applies to sponsors of clinical trials of...

Related Keywords

,King Spalding ,Drug Administration ,Data Monitoring Committees ,Clinical Trials ,Clinical Trial Data Monitoring Committees ,Institutional Review Board ,Draft Guidance ,Clinical Trial Sponsors ,